Estimated impact of the prostate cancer prevention trial on population mortality.
Zeliadt
Steven B
SB
Etzioni
Ruth
R
Kristal
Alan R
AR
D017677:Age Distribution; D000368:Aged; D016022:Case-Control Studies; D018572:Disease-Free Survival; D018120:Finasteride / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011237:Predictive Value of Tests; D011379:Prognosis; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000401:mortality* / Q000473:pathology; D018570:Risk Assessment; D016019:Survival Analysis; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology
D018120:Finasteride; D017430:Prostate-Specific Antigen